Get all your news in one place.

100’s of premium titles.
One app.

Get all your news in one place.

100’s of premium titles. One news app.

The Latest Breaking News from Brainstorm

Brainstorm Cell Therapeutics Crashes 42% After Voluntary Nasdaq Delisting Announcement

BrainStorm Cell Therapeutics Inc. (NASDAQ:BCLI) shares crashed 42.74% to $0.67 in after-hours trading on Friday after the company announced its voluntary delisting from the Nasdaq Capital Market.

Benzinga

It's getting harder to tell which company is winning the AI race, Hugging Face co-founder says

Hugging Face's Thomas Wolf says that it's getting harder to tell which AI model is the best as traditional AI benchmarks become saturated.

Fortune

AI revenue comes in hot. But can it stick?

AI startups are clocking millions in revenue from zero in just a few months. But will those numbers stick?

Fortune

From analysis to the latest developments in health,
read the most diverse news in one place.

Mark Cuban on healthcare in America, the NBA, AI, and social media

Mark Cuban is game to chat on social media—just not necessarily on X, formerly Twitter, he told the Fortune Brainstorm audience in Las Vegas.

Fortune

Exclusive: Avid Ventures raises $87 million second fund

Avid Ventures has raised $87 million for its second fund, Fortune can exclusively report.

Fortune

CEOs have much less 'FUD'—fear, uncertainty and doubt—around AI

At Fortune's Brainstorm Tech conference, speakers were optimistic about what AI can do—and how economic turmoil is separating smart money from the dumb.

Fortune

Why a ‘collective conversation’ is so important for tech and AI right now

The advent of generative AI has supercharged a tech industry that was already bringing dizzying changes to business. Leaders from VC firm Sequoia Capital as well as companies like Google, Amazon, and Salesforce, will convene at Fortune's Brainstorm Tech this July to help put things in perspective.

Fortune

Read news from The Economist, FT, and more,
with one subscription

Brainstorm Expands Operations in N. America with New Office and Staff

Thierry Gonzalo joins Brainstorm’s US team as Senior Solutions Architect in its new Austin office

TV Tech

FDA advisers vote against experimental ALS treatment pushed by patients

Federal health advisers have voted overwhelmingly against recommending approval of an experimental treatment for Lou Gehrig's disease, the fatal muscle-wasting disease

The Independent UK

FDA skeptical of experimental ALS treatment pushed by patient advocates

The Food and Drug Administration meets this week to consider a much-debated treatment for Lou Gehrig’s disease

The Independent UK

40 Years Ago, a Wild Sci-Fi Movie Predicted a Life-Changing Scientific Invention

Primitive research shows that brain patterns can be visualized, similar to technology shown in the 1983 film "Brainstorm."

Inverse

Deon Estus moved to Dublin to play with Phil Lynott. He ended up giving George Michael (and Wham!) groove

George Michael could play bass – but it was Deon Estus who gave his songs groove, especially on 1987's Faith album...

Guitar World

Stanford researchers scoured every reputable study for the link between video games and gun violence that politicians point to. Here's what the review found

The Stanford Brainstorm Lab focuses on technology and mental health. Researchers spent months looking for any causal link between video games and violence.

Fortune

Brainstorm Toys Deep Space Home Planetarium and Projector review

A hands-on multi-functional home star projector and planetarium — would it be a good gift for a budding astronomer?

LiveScience

Get all your
news in one place.

100’s of premium titles.
One news app.

The Independent UK

NIH to fund unproven ALS drugs under patient-backed law

The U.S. government will soon spend $25 million to help patients access experimental drugs for the incurable illness known as Lou Gehrig's disease

Benzinga

BCLI: Anticipating News on How NurOwn® Will be Advanced Forward…

By David Bautz, PhD NASDAQ:BCLI READ THE FULL BCLI RESEARCH REPORT

Benzinga

BCLI: Awaiting Clarity on Regulatory Environment Before Deciding on Next Steps for NurOwn®…

By David Bautz, PhD NASDAQ:BCLI READ THE FULL BCLI RESEARCH REPORT

People

From analysis to the latest developments in health,
read the most diverse news in one place.

Organisations

the Food and Drug Administration

Read news from The Economist, FT, and more,
with one subscription

Topics

Places

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.